End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
190,800 KRW | -1.09% | +0.95% | -5.31% |
May. 10 | Celltrion's Q1 Attributable Profit Slumps 86% | MT |
Apr. 24 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.31% | 28.77B | |
+29.25% | 48.16B | |
-0.82% | 41.73B | |
+43.57% | 41.03B | |
+10.22% | 25.59B | |
-21.10% | 18.96B | |
+7.83% | 12.92B | |
+27.25% | 12.03B | |
-3.58% | 11.77B | |
+20.22% | 11.73B |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Celltrion, Abpro Partner to Develop, Commercialize Breast Cancer Treatment Drug